Shruti M. Raja

Also affiliated with Duke Medical Center

MedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis”.

Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis

Journal of Neuroimmunology(2020)10.1016/j.jneuroim.2020.577279

N/A

0.494DataRank · unranked

26 citations

Jeffrey T. Guptill, Melissa A. Russo, James F. Howard, Janice M. Massey, Vern C. Juel +7 more

Perioperative Outcomes of Thymectomy in Myasthenia Gravis: A Thoracic Surgery Database Analysis

The Annals of Thoracic Surgery(2021)10.1016/j.athoracsur.2021.06.071

N/A

0.470DataRank · unranked

22 citations

Jeffrey T. Guptill, Alec McConnell, Hussein R. Al‐Khalidi, Matthew G. Hartwig, Jacob A. Klapper +1 more

Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial Decisions

Infectious Diseases and Therapy(2022)10.1007/s40121-022-00605-z

N/A

0.315DataRank · unranked

4 citations

Shruti M. Raja, Rachel L. Randell, Gregory A. Deye, Thomas Conrad, Aya Nakamura +6 more

Data from The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor–induced apoptosis

(2023)10.1158/1535-7163.c.6531011

N/A

0DataRank · unranked

0 citations

Shuzhen Chen, Ping Yue, Timothy M. Acker, Benjamin Lefkove, Jack L. Arbiser +3 more

Data from The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor–induced apoptosis

(2023)10.1158/1535-7163.c.6531011.v1

N/A

0DataRank · unranked

0 citations

Shuzhen Chen, Ping Yue, Timothy M. Acker, Benjamin Lefkove, Jack L. Arbiser +3 more

A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)‐Hydroxynorketamine in Healthy Volunteers

Clinical Pharmacology & Therapeutics(2024)10.1002/cpt.3391

N/A

0DataRank · unranked

34 citations

Jeffrey T. Guptill, Michelle Mack, Marni Peterson, Stephen J. Byard, Robert J. Twieg +36 more